Philippe Allain

Centre Hospitalier Universitaire d'Angers

Papers

2

Total Citations

24

H-Index

2

About

Philippe Allain’s research centers on clinical chemistry and analytical automation, with a particular focus on developing high-throughput methods for therapeutic drug monitoring and enzyme diagnostics. His major contributions include pioneering the integration of flow-injection analysis (FIA) with commercial HPLC instruments to automate fluoroimmunoassays, as demonstrated in his 1989 work on theophylline and valproic acid determination (15 citations). This approach streamlined drug-level testing by replacing manual steps with robotic sample preparation and injection, enhancing reproducibility in clinical labs. Allain also advanced cholinesterase phenotyping, creating an automated spectrophotometric FIA method to measure enzyme activity in plasma and erythrocytes (9 citations). This innovation enabled rapid identification of individuals sensitive to succinylcholine, a critical safety application in anesthesia. His work exemplifies the early adoption of robotic automation in clinical chemistry, bridging the gap between research instrumentation and practical diagnostics. While his citation counts reflect focused technical impact rather than broad recognition, Allain’s methods remain foundational for automated enzyme assays and drug monitoring, underscoring his role in modernizing clinical laboratory workflows.

Research Focus

Key Achievements

2
H-Index
2
Papers
24
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Automated fluoroimmunoassay of theophylline and valproic acid by flow-injection analysis with use of HPLC instruments.
15 citations · 1989
📈 Most Prolific Year: 1989 (2 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Centre Hospitalier Universitaire d'Angers

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago